Source: Wikipedia, the free encyclopedia.
Investigational analgesic drug
PF-05089771 |
|
Legal status |
|
---|
|
|
JSmol) | |
---|
|
InChI=1S/C18H12Cl2FN5O3S2/c19-9-1-2-14(10(3-9)11-6-24-25-18(11)22)29-15-5-13(21)16(4-12(15)20)31(27,28)26-17-7-30-8-23-17/h1-8,26H,(H3,22,24,25) Key:ZYSCOUXLBXGGIM-UHFFFAOYSA-N
|
PF-05089771 is a selective,
primary erythromelalgia.
[4]
See also
References
External links
VDCCsTooltip Voltage-dependent calcium channels
| |
---|
VGKCsTooltip Voltage-gated potassium channels | |
---|
IRKsTooltip Inwardly rectifying potassium channel | |
---|
KCaTooltip Calcium-activated potassium channel | |
---|
K2PsTooltip Tandem pore domain potassium channel | |
---|
VGSCsTooltip Voltage-gated sodium channels | |
---|
ENaCTooltip Epithelial sodium channel | |
---|
ASICsTooltip Acid-sensing ion channel | |
---|
CaCCsTooltip Calcium-activated chloride channel | |
---|
CFTRTooltip Cystic fibrosis transmembrane conductance regulator | |
---|
Unsorted | |
---|
Others | Tooltip Transient receptor potential channels | |
---|
Tooltip Ligand gated ion channels | |
---|
|
---|
|